Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
103 studies found for:    anakinra
Show Display Options
Rank Status Study
1 Recruiting Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease
Condition: Kawasaki Disease
Intervention: Drug: Anakinra
2 Terminated
Has Results
Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss
Condition: Hearing Loss, Sudden
Intervention: Drug: anakinra
3 Completed
Has Results
Anakinra as a Treatment for Hydradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Intervention: Drug: anakinra
4 Completed
Has Results
A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease
Conditions: Sensorineural Hearing Loss;   Autoimmune Inner Ear Disease
Intervention: Drug: Anakinra
5 Completed Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Anakinra
6 Not yet recruiting Anakinra Versus Placebo for the Treatment of Acute MyocarditIS
Condition: Acute Myocarditis
Interventions: Drug: ANAKINRA 100 mg/daily subcutaneously;   Drug: Placebo
7 Recruiting Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients
Condition: Metastatic Breast Cancer
Intervention: Drug: Anakinra plus Standard of Care
8 Recruiting Anakinra and Kawasaki Disease
Conditions: Kawasaki Disease;   Children
Intervention: Drug: Anakinra
9 Completed Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
Condition: Familial Mediterranean Fever,
Intervention: Drug: Kineret
10 Recruiting Anakinra or Denosumab and Everolimus in Advanced Cancer
Condition: Advanced Cancers
Interventions: Drug: Everolimus;   Drug: Anakinra;   Drug: Denosumab
11 Unknown  The Effect of Anakinra on Insulin Secretion
Conditions: Glucose Intolerance;   Impaired Insulin Secretion;   Diabetes Mellitus Type 2
Intervention: Drug: Anakinra
12 Completed Anakinra in Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Interventions: Drug: Water for injection;   Drug: Anakinra
13 Recruiting Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Anakinra
14 Completed
Has Results
Anakinra to Prevent Post-infarction Remodeling
Condition: ST Segment Elevation Acute Myocardial Infarction
Interventions: Drug: Anakinra;   Drug: Placebo
15 Completed
Has Results
Anakinra to Prevent Adverse Post-infarction Remodeling (2)
Conditions: Acute Myocardial Infarction;   Heart Failure
Interventions: Drug: Anakinra;   Drug: Placebo
16 Recruiting Treatment of Macrophage Activation Syndrome (MAS) With Anakinra
Condition: Macrophage Activation Syndrome
Interventions: Drug: kineret;   Drug: placebo
17 Completed
Has Results
Anakinra for Behcet s Disease
Conditions: Autoimmune Connective Tissue Disorder;   Immune System Diseases
Intervention: Drug: Anakinra
18 Recruiting Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: ANAKINRA
19 Completed
Has Results
Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: Anakinra (IL-1Ra);   Drug: Dexamethasone acetate
20 Recruiting Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study
Conditions: Gout;   Chronic Kidney Diseases
Interventions: Drug: Anakinra 100mg and Placebo Depo-Medrone;   Drug: Depo-Medrone 120mg and Placebo (Anakinra)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.